These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 6803358)

  • 61. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN; Bollinger M; Compton J
    Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.
    Gilleland LB; Gilleland HE; Gibson JA; Champlin FR
    J Med Microbiol; 1989 May; 29(1):41-50. PubMed ID: 2498520
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activity of amikacin, gentamicin and tobramycin combined with carbenicillin or ticarcillin against Pseudomonas aeruginosa in vitro.
    Meitert E; Petrescu AM; Chiru M
    Arch Roum Pathol Exp Microbiol; 1985; 44(2):127-36. PubMed ID: 3938268
    [No Abstract]   [Full Text] [Related]  

  • 64. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D; Majtán V
    Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results.
    Waitz JA; Hare RS; Moss EL; Sabatelli FJ; Schaffer TW; Waitz JA
    Scand J Infect Dis Suppl; 1980; Suppl 23():62-72. PubMed ID: 6937970
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
    Linda H; Patzer J
    Med Dosw Mikrobiol; 1984; 36(4):223-9. PubMed ID: 6100122
    [No Abstract]   [Full Text] [Related]  

  • 67. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The influence of Mg ++ and Ca ++ ions on the effect of gentamycin on Pseudomonas aeruginosa in agar diffusion test].
    Hameister W; Wahlig H
    Arzneimittelforschung; 1971 Nov; 21(11):1658-60. PubMed ID: 5003644
    [No Abstract]   [Full Text] [Related]  

  • 69. In-vitro comparison of four antipseudomonal antibiotics in a general hospital.
    Khan AJ; Evans HE; Cherubin CE; Hochstein L
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):479-82. PubMed ID: 816606
    [No Abstract]   [Full Text] [Related]  

  • 70. Aminoglycosides from the clinical microbiologist's viewpoint.
    Schoenknecht FD
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):103-11. PubMed ID: 237839
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The effect of the inoculum concentration on the in vitro sensitivity of Pseudomonas aeruginosa].
    Zarakolu P; Cöplü N; Güvener E
    Mikrobiyol Bul; 1993 Jul; 27(3):211-5. PubMed ID: 8361409
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.
    Zhanel GG; Karlowsky JA; Hoban DJ; Davidson RJ
    Chemotherapy; 1991; 37(2):114-21. PubMed ID: 1903340
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa.
    Alipour M; Suntres ZE; Omri A
    J Antimicrob Chemother; 2009 Aug; 64(2):317-25. PubMed ID: 19465435
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
    Flournoy DJ; Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):391-2. PubMed ID: 3090386
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
    Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
    Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
    J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Bacteriological studies on the therapy of bacillus pyocyaneus infections].
    Metz H; Ohgke H; Hartmann I
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):342-8. PubMed ID: 809372
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
    Hostacká A
    J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.